Should You Buy Neogen Corporation Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Neogen Corporation (NEOG) carries a solid Quality of Company rating of 6.9/10. Trading at $12.25, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 1 of 7 CirclFi valuation models project upside for Neogen Corporation (NEOG) at $12.25 — the model consensus leans bearish, with a Quality Score of 6.9/10 and Value-Trap risk of 27/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Neogen Corporation (NEOG) in 2026?
What Is the Bull Case vs the Bear Case for Neogen Corporation (NEOG)?
| Bull case — $12.76 target (+4.1%) | Bear case — $1.77 target (-85.6%) |
|---|---|
| Industry tailwind: late-stage pipeline catalysts could provide meaningful support for Neogen Corporation's revenue and margin trajectory in the Medical Devices space. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $1.77 (-85.6%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +89.7% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. | |
| Industry headwind: regulatory rejection risk represents a meaningful risk for Neogen Corporation and its Medical Devices peers. |
How Does NEOG Compare to Its Medical Devices Peers?
Valuation data pages: ATEC · SENS · CTKB · PROF · CERS · HYPR · CODX · RBOT · EW · IRMD · PODD
Which Other Stocks Score Like NEOG on Quality?
Closest companies to NEOG’s Quality of Company score of 6.9/10, across all industries.
- SOFI — SoFi Technologies, Inc. (QOC 6.9) · analysis
- CCI — Crown Castle Inc. (QOC 6.9) · analysis
- SMR — NuScale Power Corporation (QOC 6.9) · analysis
- DRVN — Driven Brands Holdings Inc. (QOC 6.9) · analysis
- OBDC — Blue Owl Capital Corporation (QOC 6.9) · analysis
- ESOA — Energy Services of America Corporation (QOC 6.8) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Devices Screens Does NEOG Appear In?
So Is Neogen Corporation (NEOG) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Neogen Corporation at $12.25. 6/7 models flag overvaluation, median fair value sits at $6.36 (-48.1%), and the risk-reward profile appears unfavorable. Quality at 6.9/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Neogen Corporation's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About NEOG Stock?
Should I buy NEOG stock right now?
Based on CirclFi's multi-model analysis, 1 of 7 models see upside for NEOG at $12.25. The models are divided, which means the investment case depends heavily on your assumptions about Neogen Corporation's future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Neogen Corporation?
Key risks include: limited model coverage (7/13 active), reducing analytical confidence; wide model disagreement (623% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Devices companies. Always diversify and consult a financial advisor.
How does NEOG compare to its competitors?
Among Medical Devices peers, NEOG holds a Quality Score of 6.9/10. Comparable companies include ATEC (QOC 6.9), SENS (QOC 6.8), CTKB (QOC 6.9). The relative ranking helps investors identify whether NEOG offers better fundamental quality than alternatives in the same sector.
Is NEOG a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. NEOG's Quality Score of 6.9/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy NEOG at?
CirclFi does not provide target buy prices or price alerts. However, our 7 active models produce fair value estimates ranging from $1.77 to $12.76. At $12.25, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for NEOG.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad